These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25130928)

  • 1. Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.
    Zhang T; Wang Y; Fan X; Ma J; Li S; Jiang T; Wang L
    J Neurol Sci; 2014 Nov; 346(1-2):94-8. PubMed ID: 25130928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
    Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
    Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM
    World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
    Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
    J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping p53 mutations in low-grade glioma: a voxel-based neuroimaging analysis.
    Wang YY; Zhang T; Li SW; Qian TY; Fan X; Peng XX; Ma J; Wang L; Jiang T
    AJNR Am J Neuroradiol; 2015 Jan; 36(1):70-6. PubMed ID: 25104286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53.
    Szybka M; Zawlik I; Kulczycka D; Golanska E; Jesien E; Kupnicka D; Stawski R; Piaskowski S; Bieniek E; Zakrzewska M; Kordek R; Liberski PP; Rieske P
    Br J Cancer; 2008 Apr; 98(8):1431-3. PubMed ID: 18349850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging characteristics in subgroup of GBMs with p53 overexpression.
    Mut M; Turba UC; Botella AC; Baskurt E; Lopes MB; Shaffrey ME
    J Neuroimaging; 2007 Apr; 17(2):168-74. PubMed ID: 17441839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of deep-seated glioblastomas.
    Hayashi Y; Yamashita J; Watanabe T
    Cancer Genet Cytogenet; 2004 Aug; 153(1):64-8. PubMed ID: 15325097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme.
    Newcomb EW; Madonia WJ; Pisharody S; Lang FF; Koslow M; Miller DC
    Brain Pathol; 1993 Jul; 3(3):229-35. PubMed ID: 8293182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and disease: when the guardian angel fails.
    Royds JA; Iacopetta B
    Cell Death Differ; 2006 Jun; 13(6):1017-26. PubMed ID: 16557268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous p53 gene mutation in a radiation-induced glioblastoma 10 years after treatment for an intracranial germ cell tumor: case report.
    Tada M; Sawamura Y; Abe H; Iggo R
    Neurosurgery; 1997 Feb; 40(2):393-6. PubMed ID: 9007876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
    Sure U; Rüedi D; Tachibana O; Yonekawa Y; Ohgaki H; Kleihues P; Hegi ME
    J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
    Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular heterogeneity of glioblastomas: does location matter?
    Denicolaï E; Tabouret E; Colin C; Metellus P; Nanni I; Boucard C; Tchoghandjian A; Meyronet D; Baeza-Kallee N; Chinot O; Figarella-Branger D
    Oncotarget; 2016 Jan; 7(1):902-13. PubMed ID: 26637806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The definition of primary and secondary glioblastoma.
    Ohgaki H; Kleihues P
    Clin Cancer Res; 2013 Feb; 19(4):764-72. PubMed ID: 23209033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.
    Fan X; Qi C; Liu X; Wang Y; Liu S; Li S; Wang L; Wang Y
    Clin Radiol; 2018 Mar; 73(3):283-289. PubMed ID: 29187298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter mutations in primary and secondary glioblastomas.
    Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H
    Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 status has no prognostic significance in glioblastomas treated with radiotherapy.
    Baxendine-Jones J; Campbell I; Ellison D
    Clin Neuropathol; 1997; 16(6):332-6. PubMed ID: 9401801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.